SARS-CoV-2 testing for asymptomatic adult cancer patients before initiating systemic treatments: a systematic review

INTRODUCTION: Cancer patients may have a higher risk of severe events and unfavourable outcomes in the setting of COVID-19. This review addresses the question of whether to test asymptomatic cancer patients before initiating systemic cancer treatments. METHODS: This systematic review was conducted b...

Descripción completa

Detalles Bibliográficos
Autores principales: Haradaa, Guilherme, Antonacio, Fernanda F, Gongora, Aline BL, Behar, Marina H, Capareli, Fernanda C, Bastos, Diogo A, Munhoz, Rodrigo R, Costa, Frederico P, Jardim, Denis L, Arrais-Rodrigues, Celso, Novis, Yana, Katz, Artur, de Castro Junior, Gilberto
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cancer Intelligence 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7532035/
https://www.ncbi.nlm.nih.gov/pubmed/33082850
http://dx.doi.org/10.3332/ecancer.2020.1100

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7532035/
https://www.ncbi.nlm.nih.gov/pubmed/33082850
http://dx.doi.org/10.3332/ecancer.2020.1100

Ejemplares similares